The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABBVIE INC | COM | 00287Y109 | 78,671 | 1,445,900 | SH | SOLE | 1,445,900 | 0 | 0 | ||
ADMA BIOLOGICS INC | COM | 000899104 | 8,796 | 1,052,142 | SH | SOLE | 1,052,142 | 0 | 0 | ||
AKORN INC | COM | 009728106 | 53,411 | 1,873,756 | SH | SOLE | 1,873,756 | 0 | 0 | ||
ANI PHARMACEUTICALS INC | COM | 00182C103 | 41,734 | 1,056,289 | SH | SOLE | 1,056,289 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 925 | 224,400 | SH | SOLE | 224,400 | 0 | 0 | ||
BIOLASE INC | COM | 090911108 | 1,039 | 1,154,372 | SH | SOLE | 1,154,372 | 0 | 0 | ||
BIOTIME INC | COM | 09066L105 | 1,619 | 539,640 | SH | SOLE | 539,640 | 0 | 0 | ||
CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 36,856 | 2,326,748 | SH | SOLE | 2,326,748 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 17,409 | 5,802,885 | SH | SOLE | 5,802,885 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 4,155 | 45,183 | SH | SOLE | 45,183 | 0 | 0 | ||
CTI BIOPHARMA CORP | COM | 12648L106 | 672 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
DERMA SCIENCES INC | COM PAR $.01 | 249827502 | 8,918 | 1,893,467 | SH | SOLE | 1,893,467 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 100,230 | 1,353,913 | SH | SOLE | 1,353,913 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 20,624 | 570,662 | SH | SOLE | 570,662 | 0 | 0 | ||
EPIRUS BIOPHARMACEUTICALS IN | COM | 29428P107 | 10,275 | 2,324,669 | SH | SOLE | 2,324,669 | 0 | 0 | ||
IMPRIVATA INC | COM | 45323J103 | 3,669 | 206,448 | SH | SOLE | 206,448 | 0 | 0 | ||
INSYS THERAPEUTICS INC NEW | COM NEW | 45824V209 | 92,697 | 3,257,094 | SH | SOLE | 3,257,094 | 0 | 0 | ||
MERUS LABS INTL INC NEW | COM | 59047R101 | 1,681 | 1,303,484 | SH | SOLE | 1,303,484 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 7,189 | 449,325 | SH | SOLE | 449,325 | 0 | 0 | ||
NEOTHETICS INC | COM | 64066G101 | 987 | 122,271 | SH | SOLE | 122,271 | 0 | 0 | ||
ORTHOFIX INTL N V | COM | N6748L102 | 60,296 | 1,786,535 | SH | SOLE | 1,786,535 | 0 | 0 | ||
OSIRIS THERAPEUTICS INC NEW | COM | 68827R108 | 37,600 | 2,035,709 | SH | SOLE | 2,035,709 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 22,904 | 6,257,861 | SH | SOLE | 6,257,861 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 69,904 | 3,450,323 | SH | SOLE | 3,450,323 | 0 | 0 | ||
SEASPINE HLDGS CORP | COM | 81255T108 | 4,026 | 248,502 | SH | SOLE | 248,502 | 0 | 0 | ||
SIENTRA INC | COM | 82621J105 | 606 | 59,664 | SH | SOLE | 59,664 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 16,207 | 1,436,796 | SH | SOLE | 1,436,796 | 0 | 0 | ||
VERACYTE INC | COM | 92337F107 | 1,251 | 266,794 | SH | SOLE | 266,794 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 6,376 | 2,352,940 | SH | SOLE | 2,352,940 | 0 | 0 |